Another in vivo study by Wang et al. found that eliminating PCSK9 had a protective effect on thrombosis, as evidenced by decreased leukocyte attachment on venous thrombosis, circulating lipid profile levels, and P-selectin levels in PCSK9-deficient mice [71]. This evidence concerns the gene PCSK9 and deep vein thrombosis.